From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid
Article in International Journal of Molecular Sciences (November 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types
Article in Frontiers in Immunology (July 2023)
Divergent in situ expression of IL‐31 and IL‐31RA between bullous pemphigoid and pemphigus vulgaris
Article in Experimental Dermatology (June 2023)